Evidence map›Paper›PMID 42842547›Full record

ArticlePLOS digital health2026

Digital solutions for tackling mental health in cancer patients and their families: The ALTHEA project.

Ilaria Durosini, Dario Monzani, Veronica Coppini, Maria Vittoria Ferrari, Chiara Bovolenta, Asia Grigis, Giuseppe Curigliano, Paola Zagami, Elisabetta Munzone, Ida Minchella and 36 more

Abstract read
In one paragraph

Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors.

Ilaria DurosiniApplied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID https://orcid.org/0000-0002-8500-2675
Dario MonzaniApplied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Veronica CoppiniApplied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Maria Vittoria FerrariApplied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Chiara BovolentaApplied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Asia GrigisApplied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Giuseppe CuriglianoDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Paola ZagamiDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Elisabetta MunzoneDivision of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Ida MinchellaDivision of New Drugs and Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
Francesca MagnoniDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.ORCID https://orcid.org/0000-0001-9208-988X
Fedro Alessandro PeccatoriGynecologic Oncology Department, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Isabelle SchollDepartment of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Marcel MeyerheimDepartment of Paediatric Oncology and Haematology, Faculty of Medicine, Saarland University, Homburg, Germany.ORCID https://orcid.org/0000-0002-9294-9445
Mieke Van HemelrijckEuropean Organisation for Research and Treatment of Cancer, EORTC, Brussels, Belgium.
Hannah GsellChildhood Cancer International Europe, Vienna, Austria.ORCID https://orcid.org/0009-0004-8529-549X
Lucija GosakFaculty of Health Sciences, University of Maribor, Maribor, Slovenia.
Laura Ciria-SuarezICOnnecta't Digital Health Program, Catalan Institute of Oncology, Hospitalet de Llobregat, Catalonia, Spain.ORCID https://orcid.org/0000-0002-1388-6686
Karl LàvoGlobal Alliance for Mental Illness Advocacy Networks, GAMIAN-Europe, Brussels, Belgium.
Norbert GrafDepartment of Paediatric Oncology and Haematology, Faculty of Medicine, Saarland University, Homburg, Germany.ORCID https://orcid.org/0000-0002-2248-323X
Marta Pérez-CampdepadrósPediatric Cancer Centre, Sant Joan de Déu Barcelona Hospital, Barcelona, Spain.
Marie LangeClinical Research Department, UNICANCER, Centre François Baclesse, Caen, France.ORCID https://orcid.org/0000-0002-1749-2713
Elisabeth AndritschDivision of Oncology, Medical University of Graz, Graz, Austria.
Birute BrasiunieneNational Cancer Center of Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania.
Andreas CharalambousDepartment of Nursing, School of Health Sciences, Cyprus University of Technology, Limassol, Cyprus.ORCID https://orcid.org/0000-0003-4050-031X
Nataliia DovganychClinical Pharmacology & Cardio-Oncology Department, NSC "The M.D.Strazhesko Institute of Cardiology", Kyiv, Ukraine.
Iva KiracInstitute for Gastroenterological Tumours (IGET), Zagreb, Croatia.
Haridimos KondylakisFoundation for Research and Technology Hellas (FORTH), Institute of Computer Science, Heraklion, Greece.
Kostyantyn KovalyovBlahodiyna Orhanizatsiya Blahodiynyy Fond Svit Proty Raku (WAC), Zaporizhzhia, Ukraine.
Cristian Ochoa-ArnedoICOnnecta't Digital Health Program, Catalan Institute of Oncology, Hospitalet de Llobregat, Catalonia, Spain.
Manolis TsiknakisFoundation for Research and Technology Hellas (FORTH), Institute of Computer Science, Heraklion, Greece.ORCID https://orcid.org/0000-0001-8454-1450
Béata JuzynaDepartment of Research & Development, Unicancer, Paris, France.
Ines Vaz-LuisCancer Survivorship Group, INSERM U981, Gustave Roussy FR Department for the Organization of Patient Pathways, Gustave Roussy, Villejuif, France.
Philip E V Van KerrebroeckPolicy Office, European Association of Urology, Arnhem, Netherlands.
Nicole EricksonThe European Society for Clinical Nutrition and Metabolism, ESPEN, Luxembourg, Luxembourg.
Margarita TareynAssociation of Cancer Patients (APOZ), Sofia, Bulgaria.
Norbert CouespelEuropean Cancer Organisation, Brussels, Belgium.
Clémentine RiallandEuropean Cancer Organisation, Brussels, Belgium.
Luigi GrassiDepartment of Neuroscience and Rehabilitation, Institute of Psychiatry, University of Ferrara, Ferrara, Italy.
Denis HorganEuropean Alliance for Personalised Medicine, Brussels, Belgium.
Saska Benedicic TomatInternational Sport and Culture Association, Copenhagen, Denmark.
Begonya Nafria EscaleraResearch Department, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Delia NicoaraDepartment of Quality Management, "Prof. Dr. Ion Chiricuta" Institute of Oncology, Cluj-Napoca, Romania.
Claudio LombardoOrganisation of European Cancer Institutes, Brussels, Belgium.
Gabriella PravettoniApplied Research Division for Cognitive and Psychological Science, IEO, European Institute of Oncology IRCCS, Milan, Italy.
ALTHEA Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite advances in cancer treatment, the growing global cancer burden underscores the need for comprehensive and supportive care to address the needs of patients and their families. However, access to psycho-oncological support remains often limited across healthcare systems. This could be related to factors such as resource constraints and insufficient integration of psychological care into routine oncological pathways. Individual-level barriers also exist, including low awareness of available services, stigma, and heterogeneity in patients' perceived needs and help-seeking attitudes. Nevertheless, psychological burden can significantly influence patients' experience of the treatment pathway, influencing cognitive clarity, perceived self-efficacy, communication, risk perception, decision-making, and all areas of daily life. In this context, digital mental health solutions have emerged as promising tools to enhance accessibility, continuity of care, and personalisation of support. In this manuscript, we aim to describe the structure of the ALTHEA project ("tAckling menTal Health cancer patients and their families: digital solutions for bEtter cAre"), which focuses on the development of a novel web-based digital platform targeting cancer patients and their informal caregivers' mental health across different stages of the care pathway. ALTHEA is distinguished by the presence of screening, classification into different support profiles, and tailored interventions within a single platform, as well as by its co-creation approach involving patients and stakeholders. In this line, the ALTHEA project represents a timely opportunity to integrate digital health solutions into psycho-oncology care, improving mental health outcomes, enhancing patient empowerment, and promoting a more holistic approach to cancer care.

Identifiers

PMID42842547
PMCPMC13645018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.